Dyne Therapeutics, Inc. DYN Gain/Loss on Asset Sales
Gain/Loss on Asset Sales at other companies
Other financials
Where this comes from
Reported directly by Dyne Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:GainLossOnDispositionOfAssets1.
The official record: Dyne Therapeutics, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Dyne Therapeutics, Inc.'s gain/loss on asset sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Dyne Therapeutics, Inc.'s gain/loss on asset sales?
- Dyne Therapeutics, Inc. (DYN) reported gain/loss on asset sales of -$30K in Q1 2026.
- How has Dyne Therapeutics, Inc.'s gain/loss on asset sales changed year-over-year?
- Dyne Therapeutics, Inc.'s gain/loss on asset sales increased by 68.4% year-over-year, from -$95K to -$30K.
- What does gain/loss on asset sales mean?
- Gains or losses on asset disposals removed from operating cash flow — the cash impact is captured in investing activities.